XNYS 29 Jul, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Jul 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 106.97 per share. | 01 Jul 2025 | 50,000 | 178,342 (0%) | 0% | 107.0 | 5,348,315 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.78 per share. | 01 Jul 2025 | 1,952 | 33,451 (0%) | 0% | 104.8 | 204,531 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,036 | 0 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,036 | 35,403 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 22,173 | 22,173 | - | - | Stock Option (Right to Buy) | |
| Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 8,350 | 8,350 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 04 Jun 2025 | 56,372 | 178,342 (0%) | 0% | 102.9 | 5,799,630 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 04 Jun 2025 | 56,372 | 234,714 (0%) | 0% | 26.2 | 1,474,128 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 56,372 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 103.39 per share. | 02 Jun 2025 | 89,921 | 1,476,882 (0%) | 0% | 103.4 | 9,296,950 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 56,212 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 49,407 | 148,221 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 02 Jun 2025 | 56,212 | 1,591,918 (0%) | 0% | 17.3 | 970,219 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 02 Jun 2025 | 49,407 | 1,641,325 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 104.05 per share. | 02 Jun 2025 | 74,522 | 1,566,803 (0%) | 0% | 104.1 | 7,754,186 | Common Stock |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 104.59 per share. | 29 May 2025 | 4,000 | 22,479 (0%) | 0% | 104.6 | 418,368 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 106.42 per share. | 21 May 2025 | 4,826 | 31,367 (0%) | 0% | 106.4 | 513,583 | Common Stock |
| David C. Habiger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 5,628 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 26,479 (0%) | 0% | 0 | Common Stock | |
| David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 41,582 (0%) | 0% | 0 | Common Stock | |
| Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 37,025 (0%) | 0% | 0 | Common Stock | |
| Yoshiaki Fujimori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 4,982 (0%) | 0% | 0 | Common Stock | |
| John E. Sununu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 54,723 (0%) | 0% | 0 | Common Stock | |
| Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 5,288 | - | - | Deferred Stock Units | |
| Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 605 | 5,893 | - | - | Deferred Stock Units | |
| Jessica L. Mega | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 8,235 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 605 | 6,639 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 6,034 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 4,204 | 25,195 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 4,204 | 4,204 | - | - | Restricted Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 104.54 per share. | 02 May 2025 | 4,572 | 18,705 (0%) | 0% | 104.5 | 477,957 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.93 per share. | 02 May 2025 | 1,918 | 23,277 (0%) | 0% | 104.9 | 201,256 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 2,102 | 24,337 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 2,102 | 2,102 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.93 per share. | 02 May 2025 | 1,017 | 23,320 (0%) | 0% | 104.9 | 106,714 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 102.13 per share. | 01 May 2025 | 91,282 | 1,535,706 (0%) | 0% | 102.1 | 9,322,266 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 102.92 per share. | 01 May 2025 | 73,161 | 1,626,988 (0%) | 0% | 102.9 | 7,529,708 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 May 2025 | 49,407 | 1,700,149 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 May 2025 | 56,212 | 1,650,742 (0%) | 0% | 17.3 | 970,219 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 49,407 | 197,628 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 56,212 | 56,212 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 May 2025 | 1,009 | 39,549 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 01 May 2025 | 3,177 | 38,540 (0%) | 0% | 22.7 | 72,150 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 May 2025 | 6,176 | 35,363 (0%) | 0% | 24.6 | 151,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 01 May 2025 | 6,952 | 29,187 (0%) | 0% | 27.1 | 188,330 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 3,177 | 6,353 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,176 | 12,351 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 1,009 | 2,018 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,952 | 13,904 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 102.06 per share. | 01 May 2025 | 17,314 | 22,235 (0%) | 0% | 102.1 | 1,766,982 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 95.09 per share. | 21 Apr 2025 | 4,826 | 36,193 (0%) | 0% | 95.1 | 458,904 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 49,407 | 247,035 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 56,211 | 112,424 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 Apr 2025 | 56,211 | 1,709,565 (0%) | 0% | 17.3 | 970,202 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 01 Apr 2025 | 164,442 | 1,594,530 (0%) | 0% | 100.0 | 16,445,072 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 Apr 2025 | 49,407 | 1,758,972 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 100.85 per share. | 21 Mar 2025 | 4,826 | 41,019 (0%) | 0% | 100.8 | 486,702 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.50 per share. | 03 Mar 2025 | 5,949 | 8,063 (0%) | 0% | 37.5 | 223,088 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,949 | 2,383 | - | - | Stock Option (Right to Buy) | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 104.63 per share. | 03 Mar 2025 | 482 | 432 (0%) | 0% | 104.6 | 50,432 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 104.97 per share. | 03 Mar 2025 | 7,149 | 914 (0%) | 0% | 105.0 | 750,465 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.16 per share. | 28 Feb 2025 | 7,218 | 11,519 (0%) | 0% | 42.2 | 304,311 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 837 | 2,514 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 7,218 | 0 | - | - | Stock Option (Right to Buy) | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.79 per share. | 28 Feb 2025 | 355 | 2,114 (0%) | 0% | 103.8 | 36,845 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 837 | 2,469 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 28 Feb 2025 | 9,887 | 1,632 (0%) | 0% | 101.1 | 999,872 | Common Stock |
| Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 104.23 per share. | 24 Feb 2025 | 13,586 | 34,944 (0%) | 0% | 104.2 | 1,416,134 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 104.00 per share. | 24 Feb 2025 | 2,688 | 25,766 (0%) | 0% | 104 | 279,552 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 104.25 per share. | 24 Feb 2025 | 4,675 | 28,454 (0%) | 0% | 104.3 | 487,369 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 5,234 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 178,342 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 1,700 | 178,682 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 104.64 per share. | 21 Feb 2025 | 4,826 | 45,845 (0%) | 0% | 104.6 | 504,993 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2025 | 1,000 | 180,382 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 105.35 per share. | 19 Feb 2025 | 1,510 | 33,129 (0%) | 0% | 105.4 | 159,079 | Common Stock |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 14,630 | 232,618 (0%) | 0% | 104.7 | 1,531,366 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 18,533 | 37,067 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 16,865 | 0 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 9,483 | 37,934 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 15,642 | 31,285 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 67,333 | 225,808 (0%) | 0% | 105.2 | 7,086,111 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 9,483 | 293,141 (0%) | 0% | 40.1 | 380,458 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 15,642 | 283,658 (0%) | 0% | 27.1 | 423,742 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 16,865 | 268,016 (0%) | 0% | 17.3 | 291,090 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 2,900 | 247,248 (0%) | 0% | 104.1 | 301,818 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 18 Feb 2025 | 18,533 | 251,151 (0%) | 0% | 24.5 | 454,985 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 105.19 per share. | 18 Feb 2025 | 3,303 | 20,991 (0%) | 0% | 105.2 | 347,443 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 104.41 per share. | 18 Feb 2025 | 2,657 | 24,294 (0%) | 0% | 104.4 | 277,417 | Common Stock |
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 4,362 | 247,700 (0%) | 0% | 0 | Common Stock | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 2,110 | 245,590 (0%) | 0% | 106.1 | 223,892 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 4,243 | 249,833 (0%) | 0% | 0 | Common Stock | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 2,052 | 247,781 (0%) | 0% | 106.1 | 217,738 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 4,584 | 252,365 (0%) | 0% | 0 | Common Stock | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 2,217 | 250,148 (0%) | 0% | 106.1 | 235,246 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 8,950 | 8,950 | - | - | Restricted Stock Units | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 23,031 | 23,031 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 4,362 | 8,725 | - | - | Restricted Stock Units | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 4,243 | 4,243 | - | - | Restricted Stock Units | ||
| Daniel J. Brennan | EVP and CFO | 13 Feb 2025 | 4,584 | 0 | - | - | Restricted Stock Units | ||
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,057 | 181,382 (0%) | 0% | 106.1 | 218,268 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 179,108 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,990 | 177,118 (0%) | 0% | 106.1 | 211,159 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 181,078 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,806 | 179,272 (0%) | 0% | 106.1 | 191,635 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 183,439 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,188 | 11,188 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,789 | 28,789 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 8,725 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 3,960 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 0 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,265 | 16,265 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 18,334 | 0 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,524 | 1,643,475 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,265 | 1,651,750 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 7,865 | 1,643,885 (0%) | 0% | 106.1 | 834,555 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 18,334 | 1,662,219 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 8,865 | 1,653,354 (0%) | 0% | 106.1 | 940,665 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 7,990 | 1,635,485 (0%) | 0% | 106.1 | 847,819 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 35,330 | 35,330 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 90,915 | 90,915 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,524 | 33,048 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,850 | 50,101 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,839 | 1,839 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,850 | 3,702 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,515 | 11,515 | - | - | Stock Option (Right to Buy) | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 484 | 50,671 (0%) | 0% | 106.1 | 51,357 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 51,155 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 890 | 50,155 (0%) | 0% | 106.1 | 94,438 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,839 | 51,045 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 895 | 49,206 (0%) | 0% | 106.1 | 94,968 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,266 | 31,211 (0%) | 0% | 106.1 | 134,335 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,334 | 0 | - | - | Restricted Stock Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,970 | 2,970 | - | - | Restricted Stock Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,776 | 5,552 | - | - | Restricted Stock Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 13,334 | 13,334 | - | - | Stock Option (Right to Buy) | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,181 | 5,181 | - | - | Restricted Stock Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,521 | 34,639 (0%) | 0% | 106.1 | 161,393 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,334 | 36,160 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,355 | 32,826 (0%) | 0% | 106.1 | 143,779 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,970 | 34,181 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,776 | 32,477 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,273 | 1,273 | - | - | Restricted Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,500 | 0 | - | - | Restricted Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,115 | 27,609 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 965 | 26,644 (0%) | 0% | 106.1 | 102,396 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 106.31 per share. | 13 Feb 2025 | 1,201 | 25,443 (0%) | 0% | 106.3 | 127,678 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,273 | 26,716 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 581 | 26,135 (0%) | 0% | 106.1 | 61,650 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,500 | 27,635 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 684 | 26,951 (0%) | 0% | 106.1 | 72,579 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,239 | 4,239 | - | - | Restricted Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 10,909 | 10,909 | - | - | Stock Option (Right to Buy) | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,115 | 4,230 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,172 | 20,935 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,534 | 19,401 (0%) | 0% | 106.1 | 162,773 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,546 | 21,947 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,231 | 20,716 (0%) | 0% | 106.1 | 130,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,834 | 23,550 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,315 | 22,235 (0%) | 0% | 106.1 | 139,535 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 8,950 | 8,950 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 23,031 | 23,031 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,172 | 6,346 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,546 | 2,546 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,834 | 0 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 667 | 0 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 661 | 1,322 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 636 | 637 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 315 | 3,552 (0%) | 0% | 106.1 | 33,425 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 661 | 3,867 (0%) | 0% | 0 | Common Stock | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 283 | 4,301 (0%) | 0% | 106.1 | 30,029 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,652 | 5,652 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,732 | 5,732 | - | - | Stock Option (Right to Buy) | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 636 | 4,188 (0%) | 0% | 0 | Common Stock | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 271 | 3,917 (0%) | 0% | 106.1 | 28,756 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 667 | 4,584 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.10 per share. | 13 Feb 2025 | 30 | 1,667 (0%) | 0% | 106.1 | 3,183 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 85 | 1,697 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 38 | 1,612 (0%) | 0% | 106.1 | 4,032 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 100 | 0 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 85 | 85 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 106 | 212 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 188 | 188 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 990 | 990 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,123 | 2,248 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 6,061 | 6,061 | - | - | Stock Option (Right to Buy) | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,355 | 2,355 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 36 | 1,731 (0%) | 0% | 106.1 | 3,820 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 100 | 1,767 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,123 | 13,702 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 330 | 13,372 (0%) | 0% | 106.1 | 35,016 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 990 | 14,362 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 291 | 14,071 (0%) | 0% | 106.1 | 30,878 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 15,071 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 294 | 14,777 (0%) | 0% | 106.1 | 31,196 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 106 | 1,650 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 13,704 | 1,633,577 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,442 | 4,328 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 424 | 48,251 (0%) | 0% | 105.8 | 44,846 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,442 | 48,675 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,115 | 6,347 | - | - | Restricted Stock Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 868 | 29,701 (0%) | 0% | 105.8 | 91,808 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,115 | 30,569 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 530 | 25,494 (0%) | 0% | 105.8 | 56,058 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,731 | 5,193 | - | - | Restricted Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,731 | 26,024 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 950 | 17,763 (0%) | 0% | 105.8 | 100,482 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,692 | 8,078 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,692 | 18,713 (0%) | 0% | 0 | Common Stock | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 231 | 3,206 (0%) | 0% | 105.8 | 24,433 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 480 | 1,443 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 480 | 3,437 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 65 | 196 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 961 | 2,885 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.78 per share. | 12 Feb 2025 | 23 | 1,544 (0%) | 0% | 105.8 | 2,433 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 65 | 1,567 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 338 | 12,579 (0%) | 0% | 105.8 | 35,750 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 961 | 12,917 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 12 Feb 2025 | 3,654 | 245,105 (0%) | 0% | 0 | Common Stock | ||
| Daniel J. Brennan | EVP and CFO | 12 Feb 2025 | 1,767 | 243,338 (0%) | 0% | 105.8 | 186,896 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 12 Feb 2025 | 3,654 | 10,963 | - | - | Restricted Stock Units | ||
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 176,325 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 1,579 | 174,746 (0%) | 0% | 105.8 | 167,011 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 10,386 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 6,626 | 1,626,951 (0%) | 0% | 105.8 | 700,832 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 13,704 | 41,112 | - | - | Restricted Stock Units | |
| Edward J. Ludwig | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 3,000 | 36,398 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 105.48 per share. | 11 Feb 2025 | 12,000 | 24,398 (0%) | 0% | 105.5 | 1,265,815 | Common Stock |
| Daniel J. Brennan | EVP and CFO | 11 Feb 2025 | 15,087 | 241,451 (0%) | 0% | 105.1 | 1,585,135 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 11 Feb 2025 | 15,087 | 256,538 (0%) | 0% | 16.3 | 246,069 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 11 Feb 2025 | 15,087 | 0 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 11 Feb 2025 | 33,944 | 257,865 (0%) | 0% | 0 | Common Stock | ||
| Daniel J. Brennan | EVP and CFO | 11 Feb 2025 | 16,414 | 241,451 (0%) | 0% | 106.0 | 1,739,556 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 130,118 | 1,682,788 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 62,915 | 1,619,873 (0%) | 0% | 106.0 | 6,667,732 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 6,350 | 47,233 (0%) | 0% | 106.0 | 672,973 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,708 | 53,583 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 10,738 | 41,476 (0%) | 0% | 106.0 | 1,138,013 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 105.06 per share. | 11 Feb 2025 | 13,022 | 28,454 (0%) | 0% | 105.1 | 1,368,073 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 23,760 | 52,214 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 105.06 per share. | 11 Feb 2025 | 6,389 | 24,293 (0%) | 0% | 105.1 | 671,249 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 10,182 | 36,631 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 3,793 | 32,838 (0%) | 0% | 106.0 | 401,982 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 2,156 | 30,682 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,366 | 25,868 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 9,847 | 16,021 (0%) | 0% | 106.0 | 1,043,585 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 104.97 per share. | 07 Feb 2025 | 6,528 | 26,449 (0%) | 0% | 105.0 | 685,244 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 101.45 per share. | 03 Feb 2025 | 8,508 | 14,307 (0%) | 0% | 101.5 | 863,169 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 03 Feb 2025 | 1,009 | 22,815 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 03 Feb 2025 | 3,176 | 21,806 (0%) | 0% | 22.7 | 72,127 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 03 Feb 2025 | 6,176 | 18,630 (0%) | 0% | 24.6 | 151,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 03 Feb 2025 | 6,952 | 12,454 (0%) | 0% | 27.1 | 188,330 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 3,176 | 9,530 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 6,176 | 18,527 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 1,009 | 3,027 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 6,952 | 20,856 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 102.14 per share. | 03 Feb 2025 | 8,805 | 5,502 (0%) | 0% | 102.1 | 899,338 | Common Stock |
| Daniel J. Brennan | EVP and CFO | 01 Jan 2025 | 14,901 | 238,822 (0%) | 0% | 0 | Common Stock | ||
| Daniel J. Brennan | EVP and CFO | 01 Jan 2025 | 14,901 | 0 | - | - | Performance Share Units | ||
| Daniel J. Brennan | EVP and CFO | 01 Jan 2025 | 9,689 | 223,921 (0%) | 0% | 89.9 | 870,636 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 01 Jan 2025 | 5,212 | 233,610 (0%) | 0% | 89.3 | 465,536 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 162,025 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 6,425 | 155,600 (0%) | 0% | 89.3 | 573,881 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 0 | - | - | Performance Share Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 57,121 | 0 | - | - | Performance Share Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 57,121 | 1,578,326 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 25,656 | 1,552,670 (0%) | 0% | 89.3 | 2,291,594 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 6,456 | 0 | - | - | Performance Share Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 6,456 | 40,866 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 1,991 | 38,875 (0%) | 0% | 89.3 | 177,836 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 10,430 | 0 | - | - | Performance Share Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 10,430 | 38,884 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 3,278 | 35,606 (0%) | 0% | 89.3 | 292,791 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 89.86 per share. | 01 Jan 2025 | 7,152 | 28,454 (0%) | 0% | 89.9 | 642,658 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 2,127 | 39,438 (0%) | 0% | 89.3 | 189,984 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 90.02 per share. | 01 Jan 2025 | 4,119 | 35,319 (0%) | 0% | 90.0 | 370,792 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 89.86 per share. | 01 Jan 2025 | 2,342 | 32,977 (0%) | 0% | 89.9 | 210,449 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 4,469 | 0 | - | - | Performance Share Units | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 4,469 | 41,565 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 4,416 | 5,502 (0%) | 0% | 89.3 | 394,437 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 8,940 | 0 | - | - | Performance Share Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 8,940 | 9,918 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Purchase of securities on an exchange or from another person at price $ 90.30 per share. | 03 Dec 2024 | 50 | 148,168 (0%) | 0% | 90.3 | 4,515 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 03 Dec 2024 | 14,447 | 172,863 (0%) | 0% | 106.0 | 1,531,093 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2024 | 31,680 | 187,310 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 89.95 per share. | 03 Dec 2024 | 20 | 148,148 (0%) | 0% | 90.0 | 1,799 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 3,066 | 35,094 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 1,197 | 13,183 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 3,066 | 0 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 6,983 | 29,308 (0%) | 0% | 90.8 | 633,917 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 1,197 | 36,291 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Emily Woodworth | SVP, Global Controller and CAO | 27 Nov 2024 | 1,336 | 2,957 (0%) | 0% | 90.6 | 121,105 | Common Stock | |
| F. Michael Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Nov 2024 | 7,800 | 201,478 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 3,177 | 12,706 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 89.27 per share. | 25 Nov 2024 | 14,010 | 978 (0%) | 0% | 89.3 | 1,250,664 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 1,009 | 4,036 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 25 Nov 2024 | 3,177 | 13,979 (0%) | 0% | 22.7 | 72,150 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 25 Nov 2024 | 1,009 | 14,988 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 1,113 | 159,354 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 11,236 | 148,118 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 91.63 per share. | 21 Nov 2024 | 4,877 | 39,398 (0%) | 0% | 91.6 | 446,902 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 2,610 | 37,096 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 87.66 per share. | 08 Nov 2024 | 30,580 | 39,706 (0%) | 0% | 87.7 | 2,680,572 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 08 Nov 2024 | 17,362 | 70,286 (0%) | 0% | 24.5 | 426,237 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 17,362 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 85.17 per share. | 05 Nov 2024 | 2,596 | 1,681,387 (0%) | 0% | 85.2 | 221,108 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.74 per share. | 05 Nov 2024 | 160,182 | 1,521,205 (0%) | 0% | 84.7 | 13,573,743 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 56,211 | 168,635 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 55,676 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 05 Nov 2024 | 56,211 | 1,628,307 (0%) | 0% | 17.3 | 970,202 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 05 Nov 2024 | 55,676 | 1,683,983 (0%) | 0% | 16.3 | 908,076 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 01 Nov 2024 | 3,066 | 37,814 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Nov 2024 | 1,197 | 14,380 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Nov 2024 | 3,066 | 3,066 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Nov 2024 | 6,983 | 32,028 (0%) | 0% | 84.3 | 588,876 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Nov 2024 | 1,197 | 39,011 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 07 Oct 2024 | 59,021 | 235,376 (0%) | 0% | 17.3 | 1,018,702 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 59,021 | 0 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 57,618 | 0 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 07 Oct 2024 | 132,527 | 160,467 (0%) | 0% | 85.0 | 11,264,888 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.98 per share. | 07 Oct 2024 | 57,618 | 292,994 (0%) | 0% | 25.0 | 1,439,298 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.94 per share. | 07 Oct 2024 | 82,085 | 1,572,096 (0%) | 0% | 84.9 | 6,972,431 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 56,211 | 224,846 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 55,675 | 55,676 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 07 Oct 2024 | 56,211 | 1,679,198 (0%) | 0% | 17.3 | 970,202 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 07 Oct 2024 | 55,675 | 1,734,873 (0%) | 0% | 16.3 | 908,059 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.31 per share. | 07 Oct 2024 | 80,692 | 1,654,181 (0%) | 0% | 84.3 | 6,803,360 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 01 Oct 2024 | 1,197 | 15,577 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Oct 2024 | 3,066 | 6,132 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Oct 2024 | 6,983 | 34,748 (0%) | 0% | 83.9 | 585,594 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Oct 2024 | 1,197 | 41,731 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Oct 2024 | 3,066 | 40,534 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.17 per share. | 05 Sep 2024 | 162,777 | 1,622,987 (0%) | 0% | 81.2 | 13,212,544 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 05 Sep 2024 | 55,675 | 1,785,764 (0%) | 0% | 16.3 | 908,059 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 55,675 | 111,351 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 05 Sep 2024 | 56,211 | 1,730,089 (0%) | 0% | 17.3 | 970,202 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2024 | 56,211 | 281,057 | - | - | Stock Option (Right to Buy) | |
| Wendy Carruthers | EVP, Human Resources | 03 Sep 2024 | 3,066 | 43,254 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 03 Sep 2024 | 1,197 | 16,774 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 03 Sep 2024 | 3,066 | 9,198 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 03 Sep 2024 | 6,983 | 37,468 (0%) | 0% | 81.7 | 570,511 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 03 Sep 2024 | 1,197 | 44,451 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Aug 2024 | 95,041 | 385,523 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Aug 2024 | 176,245 | 209,278 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Aug 2024 | 114,237 | 290,482 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 28 Aug 2024 | 14,132 | 176,355 (0%) | 0% | 80 | 1,130,560 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 26 Aug 2024 | 3,176 | 23,805 (0%) | 0% | 22.7 | 72,127 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 3,176 | 15,883 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 1,009 | 5,045 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 79.25 per share. | 26 Aug 2024 | 14,012 | 10,802 (0%) | 0% | 79.3 | 1,110,515 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 26 Aug 2024 | 1,009 | 24,814 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | 06 Aug 2024 | 10,843 | 13,381 (0%) | 0% | 73.8 | 799,780 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Aug 2024 | 1,197 | 17,971 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Aug 2024 | 3,066 | 12,264 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Aug 2024 | 6,983 | 40,188 (0%) | 0% | 74.1 | 517,580 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Aug 2024 | 1,197 | 47,171 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Aug 2024 | 3,066 | 45,974 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| David C. Habiger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 1,252 | 3,547 (0%) | 0% | 0 | Common Stock | |
| David C. Habiger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 2,155 | 2,295 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2024 | 1,952 | 34,410 (0%) | 0% | 76.4 | 149,152 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2024 | 4,036 | 36,362 (0%) | 0% | 0 | Common Stock | ||
| Vance R. Brown | SVP, GC and Corp. Secretary | 01 Jul 2024 | 4,036 | 4,036 | - | - | Restricted Stock Units | ||
| Wendy Carruthers | EVP, Human Resources | 01 Jul 2024 | 6,983 | 42,908 (0%) | 0% | 77.3 | 539,786 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Jul 2024 | 3,066 | 48,694 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Jul 2024 | 1,197 | 49,891 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Jul 2024 | 1,197 | 19,168 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Jul 2024 | 3,066 | 15,330 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 03 Jun 2024 | 3,066 | 18,396 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 03 Jun 2024 | 1,197 | 20,365 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 03 Jun 2024 | 1,197 | 52,611 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 03 Jun 2024 | 6,983 | 45,628 (0%) | 0% | 75.3 | 526,029 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 03 Jun 2024 | 3,066 | 51,414 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Cheryl Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 407 | 3,207 | - | - | Deferred Stock Units | |
| Cheryl Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 2,800 | 2,800 | - | - | Deferred Stock Units | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 33,726 | 0 | - | - | Stock Option (Right to Buy) | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 29 May 2024 | 63,802 | 28,022 (0%) | 0% | 75.1 | 4,791,447 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 29 May 2024 | 33,726 | 91,824 (0%) | 0% | 17.3 | 582,111 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 1,009 | 6,054 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,177 | 19,059 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 28 May 2024 | 3,177 | 33,199 (0%) | 0% | 22.7 | 72,150 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 28 May 2024 | 1,009 | 34,208 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 75.34 per share. | 28 May 2024 | 14,011 | 20,197 (0%) | 0% | 75.3 | 1,055,590 | Common Stock |
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 16,863 | 288,405 (0%) | 0% | 24.6 | 413,987 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 64,454 | 271,542 (0%) | 0% | 75.9 | 4,892,819 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 15,086 | 335,996 (0%) | 0% | 16.3 | 246,053 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 15,642 | 320,910 (0%) | 0% | 27.1 | 423,742 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 47,621 | 223,921 (0%) | 0% | 75.1 | 3,576,932 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 15,642 | 46,927 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 16,863 | 16,865 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 15,086 | 15,087 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 16,863 | 55,600 | - | - | Stock Option (Right to Buy) | ||
| Daniel J. Brennan | EVP and CFO | 22 May 2024 | 16,863 | 305,268 (0%) | 0% | 17.3 | 291,055 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 32,326 (0%) | 0% | 75.6 | 1,363,606 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 0 | - | - | Stock Option (Right to Buy) | ||
| Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 0 | - | - | Stock Option (Right to Buy) | ||
| Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 32,326 (0%) | 0% | 76.0 | 1,140,633 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 15,006 | 47,332 (0%) | 0% | 27.1 | 406,513 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | 21 May 2024 | 18,037 | 50,363 (0%) | 0% | 24.5 | 442,808 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2024 | 2,380 | 190,487 (0%) | 0% | 0 | Common Stock | |
| Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 10 May 2024 | 12,931 | 44,352 (0%) | 0% | 16.3 | 210,905 | Common Stock | |
| Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 10 May 2024 | 12,931 | 0 | - | - | Stock Option (Right to Buy) | ||
| Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 10 May 2024 | 12,931 | 31,421 (0%) | 0% | 74.1 | 958,717 | Common Stock | |
| Charles J. Dockendorff | Director | 09 May 2024 | 2,901 | 2,901 (0%) | 0% | 0 | Common Stock | ||
| Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 44,275 (0%) | 0% | 0 | Common Stock | |
| David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 39,501 (0%) | 0% | 0 | Common Stock | |
| Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 48,530 (0%) | 0% | 0 | Common Stock | |
| Yoshiaki Fujimori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 2,901 (0%) | 0% | 0 | Common Stock | |
| John E. Sununu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 52,642 (0%) | 0% | 0 | Common Stock | |
| Jessica L. Mega | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 6,154 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,450 | 3,532 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 421 | 3,953 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,450 | 3,532 | - | - | Deferred Stock Units | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 421 | 3,953 | - | - | Deferred Stock Units | |
| Charles J. Dockendorff | Director | 07 May 2024 | 3,946 | 0 (0%) | 0% | 72.7 | 286,874 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 2,102 | 4,204 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.03 per share. | 02 May 2024 | 1,017 | 30,022 (0%) | 0% | 72.0 | 73,255 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 2,102 | 31,039 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 4,203 | 54,841 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 4,203 | 8,408 | - | - | Restricted Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.03 per share. | 02 May 2024 | 1,917 | 52,924 (0%) | 0% | 72.0 | 138,082 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 01 May 2024 | 3,066 | 54,134 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 May 2024 | 1,197 | 55,331 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 May 2024 | 1,197 | 21,562 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 May 2024 | 3,066 | 21,462 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 May 2024 | 6,983 | 48,348 (0%) | 0% | 71.5 | 499,075 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 01 May 2024 | 17,587 | 50,638 (0%) | 0% | 71.5 | 1,257,488 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 17,587 | 0 | - | - | Stock Option (Right to Buy) | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 May 2024 | 17,587 | 68,225 (0%) | 0% | 17.3 | 303,552 | Common Stock |
| Edward J. Ludwig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.37 per share. | 26 Apr 2024 | 9,818 | 51,192 (0%) | 0% | 17.4 | 170,539 | Common Stock |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 73.29 per share. | 26 Apr 2024 | 9,818 | 41,374 (0%) | 0% | 73.3 | 719,562 | Common Stock |
| Edward J. Ludwig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2024 | 9,818 | 0 | - | - | Stock Option (Right to Buy) | |
| Wendy Carruthers | EVP, Human Resources | 01 Apr 2024 | 1,197 | 22,759 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Apr 2024 | 1,197 | 58,051 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Apr 2024 | 3,066 | 56,854 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Apr 2024 | 6,983 | 51,068 (0%) | 0% | 68.4 | 477,777 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Apr 2024 | 3,066 | 24,528 | - | - | Stock Option (Right to Buy) | ||
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 16,351 | 0 | - | - | Stock Option (Right to Buy) | |
| John Bradley Sorenson | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 69.30 per share. | 01 Apr 2024 | 16,351 | 50,638 (0%) | 0% | 69.3 | 1,133,069 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 01 Apr 2024 | 16,351 | 66,989 (0%) | 0% | 16.3 | 266,685 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 66.45 per share. | 18 Mar 2024 | 14,506 | 58,098 (0%) | 0% | 66.5 | 963,930 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 01 Mar 2024 | 6,983 | 53,788 (0%) | 0% | 66.3 | 463,322 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Mar 2024 | 1,197 | 60,771 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Mar 2024 | 3,066 | 59,574 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 01 Mar 2024 | 1,197 | 23,956 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 01 Mar 2024 | 3,066 | 27,594 | - | - | Stock Option (Right to Buy) | ||
| Emily Woodworth | SVP, Global Controller and CAO | 01 Mar 2024 | 3,351 | 3,351 | - | - | Restricted Stock Units | ||
| Emily Woodworth | SVP, Global Controller and CAO | 01 Mar 2024 | 3,421 | 3,421 | - | - | Stock Option (Right to Buy) | ||
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 3,176 | 22,236 | - | - | Stock Option (Right to Buy) | |
| C. Arthur Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 26 Feb 2024 | 3,176 | 37,263 (0%) | 0% | 22.7 | 72,127 | Common Stock |
| C. Butcher Arthur | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 67.07 per share. | 26 Feb 2024 | 9,335 | 28,937 (0%) | 0% | 67.1 | 626,098 | Common Stock |
| Arthur Butcher C. | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,009 | 7,063 | - | - | Stock Option (Right to Buy) | |
| C. Arthur Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 26 Feb 2024 | 1,009 | 38,272 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 23 Feb 2024 | 3,066 | 30,660 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 23 Feb 2024 | 3,066 | 62,294 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Carruthers Wendy | EVP, Human Resources | 23 Feb 2024 | 1,197 | 25,153 | - | - | Stock Option (Right to Buy) | ||
| Carruthers Wendy | EVP, Human Resources | 23 Feb 2024 | 6,983 | 56,508 (0%) | 0% | 66.9 | 467,093 | Common Stock | |
| Carruthers Wendy | EVP, Human Resources | 23 Feb 2024 | 1,197 | 63,491 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 66.35 per share. | 21 Feb 2024 | 4,960 | 72,604 (0%) | 0% | 66.4 | 329,096 | Common Stock |
| Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | 20 Feb 2024 | 67,974 | 0 (0%) | 0% | 66.2 | 4,501,238 | Common Stock | |
| Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr | 18 Feb 2024 | 2,002 | 0 | - | - | Deferred Stock Units | ||
| Francis Yves Thepaut Eric | EVP & Pres, Eur, Mid-East, Afr | 18 Feb 2024 | 1,160 | 30,043 (0%) | 0% | 65.8 | 76,351 | Common Stock | |
| Eric Thepaut Francis Yves | EVP & Pres, Eur, Mid-East, Afr | 18 Feb 2024 | 2,002 | 31,203 (0%) | 0% | 0 | Common Stock | ||
| J. Daniel Brennan | EVP and CFO | 16 Feb 2024 | 3,706 | 273,186 (0%) | 0% | 0 | Common Stock | ||
| C. Arthur Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,546 | 32,321 (0%) | 0% | 0 | Common Stock | |
| Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 16 Feb 2024 | 1,448 | 29,201 (0%) | 0% | 65.8 | 95,307 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 16 Feb 2024 | 2,051 | 4,102 | - | - | Restricted Stock Units | ||
| Wendy Carruthers | EVP, Human Resources | 16 Feb 2024 | 2,250 | 2,250 | - | - | Restricted Stock Units | ||
| Carruthers Wendy | EVP, Human Resources | 16 Feb 2024 | 2,051 | 60,905 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,273 | 49,759 (0%) | 0% | 0 | Common Stock | |
| Vance Brown R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 741 | 32,544 (0%) | 0% | 0 | Common Stock | ||
| F. Mahoney Michael | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 18,333 | 18,334 | - | - | Restricted Stock Units | |
| B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,970 | 75,574 (0%) | 0% | 0 | Common Stock | |
| John Sorenson Bradley | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 581 | 49,178 (0%) | 0% | 65.8 | 38,241 | Common Stock |
| Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,706 | 0 | - | - | Deferred Stock Units | |
| Brown Vance R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 540 | 31,097 (0%) | 0% | 65.8 | 35,543 | Common Stock | |
| R. Brown Vance | SVP, GC and Corp. Secretary | 16 Feb 2024 | 218 | 32,326 (0%) | 0% | 65.8 | 14,349 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,500 | 50,678 (0%) | 0% | 0 | Common Stock | |
| Carruthers Wendy | EVP, Human Resources | 16 Feb 2024 | 998 | 61,247 (0%) | 0% | 65.8 | 65,688 | Common Stock | |
| Brennan J. Daniel | EVP and CFO | 16 Feb 2024 | 1,882 | 266,930 (0%) | 0% | 65.8 | 123,873 | Common Stock | |
| Arthur Butcher C. | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,372 | 0 | - | - | Deferred Stock Units | |
| Brown Vance R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 741 | 0 | - | - | Deferred Stock Units | ||
| Vance R. Brown | SVP, GC and Corp. Secretary | 16 Feb 2024 | 294 | 31,803 (0%) | 0% | 65.8 | 19,351 | Common Stock | |
| Mahoney Michael F. | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 18,333 | 1,672,935 (0%) | 0% | 0 | Common Stock | |
| Vance Brown R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,838 | 31,637 (0%) | 0% | 0 | Common Stock | ||
| M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,829 | 192,867 (0%) | 0% | 65.8 | 120,385 | Common Stock |
| Brown R. Vance | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,000 | 32,097 (0%) | 0% | 0 | Common Stock | ||
| Daniel Brennan J. | EVP and CFO | 16 Feb 2024 | 13,662 | 0 | - | - | Stock Option (Right to Buy) | ||
| Mirviss B. Jeffrey | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,817 | 0 | - | - | Deferred Stock Units | |
| John Bradley Sorenson | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,186 | 0 | - | - | Deferred Stock Units | |
| Butcher Arthur C. | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,130 | 31,191 (0%) | 0% | 65.8 | 74,377 | Common Stock |
| Sorenson John Bradley | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 685 | 49,993 (0%) | 0% | 65.8 | 45,087 | Common Stock |
| J. Brennan Daniel | EVP and CFO | 16 Feb 2024 | 2,033 | 269,480 (0%) | 0% | 65.8 | 133,812 | Common Stock | |
| Brown Vance R. | SVP, GC and Corp. Secretary | 16 Feb 2024 | 1,000 | 1,000 | - | - | Restricted Stock Units | ||
| Daniel Brennan J. | EVP and CFO | 16 Feb 2024 | 4,243 | 268,812 (0%) | 0% | 0 | Common Stock | ||
| Monson Jonathan R. | SVP, Global Controller and CAO | 16 Feb 2024 | 990 | 1,980 | - | - | Restricted Stock Units |